FindTrial
Sign In

Sitafloxacin

DRUG5 trials

Sponsors

Mahidol University, Khon Kaen University, Daiichi Sankyo, First Affiliated Hospital of Zhejiang University, Beijing Chest Hospital

Conditions

Acute PyelonephritisAnti-Infective Agents, UrinaryCOPD Exacerbation AcuteEscherichia Coli InfectionsFluoroquinoloneInfection Due to Escherichia ColiKidney TransplantationKlebsiella Infections

Phase 2

Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli
NCT02537847
Mahidol UniversityAcute Pyelonephritis, Infection Due to Escherichia Coli
Start: 2012-11-30End: 2016-05-31Target: 96Updated: 2015-09-02
Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
NCT02729116
Khon Kaen UniversityAnti-Infective Agents, Urinary, Escherichia Coli Infections, Kidney Transplantation +2
Start: 2016-07-31End: 2024-01-31Target: 30Updated: 2023-03-08
Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease
Enrolling by invitationNCT06809413
Beijing Chest HospitalFluoroquinolone, Mycobacterium
Start: 2025-01-28End: 2025-05-31Target: 12Updated: 2025-02-05

Phase 3

Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
Not yet recruitingNCT05454345
First Affiliated Hospital of Zhejiang UniversityTuberculosis, Pulmonary
Start: 2022-10-01End: 2026-06-30Target: 620Updated: 2022-07-12

Phase 4

A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
CompletedNCT05400369
Daiichi SankyoCOPD Exacerbation Acute
Start: 2022-08-10End: 2024-09-25Updated: 2025-01-09